REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.00
Bid: 47.00
Ask: 49.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.255%)
Open: 48.00
High: 48.00
Low: 48.00
Prev. Close: 48.00
MIG3 Live PriceLast checked at -
Maven Income and Growth VCT 3 is an Investment Trust

To achieve long-term capital appreciation and generate income for Shareholders by investing in a diversified portfolio of securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Results

30 Apr 2014 14:18

RNS Number : 9455F
Maven Income and Growth VCT 3 PLC
30 April 2014
 

 

Maven Income and Growth VCT 3 PLC (the Company) - Result of Annual General Meeting

 

At the Annual General Meeting of the Company held at 1-2 Royal Exchange Buildings, London EC3V 3LF at 10.00am on 30 April 2014, all of the Resolutions put to the Meeting were duly passed. In accordance with the provisions of D.2.2 of the Combined Code on Corporate Governance, the Company advises that for the Annual General Meeting, valid proxy appointments were made in respect of 4,418,229 shares and that the number of proxy votes lodged for each Resolution were as follows:

 

Resolutions

For

Discretion

Against

Withheld

Total

1

To receive the Annual Report and audited Financial Statements

4,168,510

201,640

5,940

42,139

4,418,229

2

To approve the Directors' Remuneration Report

3,943,634

201,640

162,878

110,077

4,418,229

3

To approve the Directors' remuneration policy for the three-year period ending 30 November 2016.

3,890,232

222,300

175,997

129,700

4,418,229

4

To approve a final dividend of 3.25p per ordinary share of 10p each in the capital of the Company (Ordinary Shares) for payment on 30 May 2014 to shareholders on the register at the close of business on 9 May 2014.

4,210,487

201,640

6,102

0

4,418,229

5

To re-elect Mr Michie as a Director

4,100,396

233,402

40,393

44,038

4,418,229

6

To re-elect Mr Nixon as a Director

4,103,242

235,821

38,885

40,281

 

4,418,229

7

To elect Mr Devani as a Director

4,087,110

230,751

33,127

67,241

4,418,229

8

To re-appoint Deloitte LLP as Auditor

 

3,850,813

275,153

242,300

49,963

4,418,229

9

To authorise the Directors to fix the remuneration of the Auditor

4,067,370

274,759

47,965

28,135

4,418,229

10

To authorise the Directors to allot new shares

4,075,578

262,554

41,789

38,308

4,418,229

11

To authorise disapplication of pre-emption rights

3,709,531

267,554

320,113

121,031

4,418,229

12

To authorise the Company to purchase its own shares

3,887,938

241,894

255,072

43,325

4,418,229

13

To allow a General Meeting to be called on not less than 14 days' notice

4,063,604

241,894

77,366

35,365

4,418,229

 

A vote withheld is not a vote in law and any such votes have not been included in the votes for or against the respective Resolutions. The voting figures will be available to view at: www.mavencp.com/migvct3.

 

Passing of Resolutions under Special Business

The Special Resolutions have been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.//hemscott.com/nsm.do.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP, Secretary

30 April 2014

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGIMMJTMBBJBRI
Date   Source Headline
3rd May 20249:35 amRNSDirector/PDMR Shareholding
3rd May 20249:33 amRNSIssue of Equity
2nd May 20241:31 pmRNSResult of AGM
1st May 202410:06 amRNSDirector/PDMR Shareholding
1st May 202410:03 amRNSIssue of Equity
26th Apr 20242:40 pmRNSNet Asset Value - Dividend Investment Scheme
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:37 pmRNSIssue of Equity
28th Mar 202410:16 amRNSStatement re Offer for Subscription
27th Mar 202410:36 amRNSIssue of Equity
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
20th Mar 20243:46 pmRNSUnaudited Net Asset Value
15th Mar 20245:18 pmRNSAnnual Financial Report
21st Feb 20244:24 pmRNSTransaction in Own Shares
8th Feb 202410:30 amRNSDirector/PDMR Shareholding
8th Feb 202410:28 amRNSDirector/PDMR Shareholding
8th Feb 202410:15 amRNSIssue of Equity
6th Feb 202411:07 amRNSDividend Declaration
19th Dec 20233:25 pmRNSIssue of Equity
18th Dec 20235:17 pmRNSUnaudited Net Asset Value
5th Dec 202311:42 amRNSDirectorate Change
9th Nov 20233:47 pmRNSResult of General Meeting
8th Nov 20234:01 pmRNSTransaction in Own Shares
7th Nov 20234:47 pmRNSTransaction in Own Shares
19th Oct 20234:15 pmRNSNet Asset Value
13th Oct 20234:56 pmRNSPublication of a Prospectus
25th Aug 20239:38 amRNSIssue of Equity
21st Aug 20233:28 pmRNSStatement re Dividend Investment Scheme
21st Jul 202312:52 pmRNSHalf-year Report
13th Jul 20234:04 pmRNSTransaction in Own Shares
6th Jul 20234:01 pmRNSStatement re Intended Offers for Subscription
30th Jun 20234:22 pmRNSNet Asset Value and Interim Dividend
2nd Jun 20239:41 amRNSIssue of Equity
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
26th Apr 202310:15 amRNSIssue of Equity - Dividend Investment Scheme
24th Apr 202312:51 pmRNSResult of AGM
19th Apr 20234:49 pmRNSTransaction in Own Shares
19th Apr 20231:05 pmRNSNet Asset Value - Dividend Investment Scheme
5th Apr 202312:29 pmRNSIssue of Equity
4th Apr 202311:43 amRNSNet Asset Value(s)
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
14th Mar 20234:31 pmRNSAnnual Financial Report
3rd Mar 20239:53 amRNSIssue of Equity
21st Feb 20234:41 pmRNSTransaction in Own Shares
16th Feb 20237:00 amRNSStatement re Offer for Subscription
8th Feb 202311:06 amRNSDirector/PDMR Shareholding - Replacement
8th Feb 202310:19 amRNSDirector/PDMR Shareholding
8th Feb 202310:19 amRNSDirector/PDMR Shareholding
8th Feb 202310:08 amRNSDirector/PDMR Shareholding
8th Feb 20239:43 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.